Inventor
GAVAI ASHVINIKUMAR V
US59 patents
⚠️ This page may combine multiple inventors who share the name “GAVAI ASHVINIKUMAR V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
36 patentsUS5770615AJun 23, 1998
Catecholamine surrogates useful as β3 agonists
BRISTOL MYERS SQUIBB CO254 citations98
US6916815B2Jul 12, 2005
C-6 modified indazolylpyrrolotriazines
BRISTOL MYERS SQUIBB CO55 citations96
US5776983AJul 7, 1998
Catecholamine surrogates useful as β3 agonists
BRISTOL MYERS SQUIBB CO300 citations96
US9458156B2Oct 4, 2016
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO25 citations94
US9273057B2Mar 1, 2016
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO29 citations93
US8822454B2Sep 2, 2014
Bisfluoroalkyl-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO9 citations84
US7151176B2Dec 19, 2006
Pyrrolotriazine compounds
BRISTOL MYERS SQUIBB CO12 citations84
US7148220B2Dec 12, 2006
C-6 modified indazolylpyrrolotriazines
BRISTOL MYERS SQUIBB CO13 citations84
US9273014B2Mar 1, 2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO14 citations83
US8999918B2Apr 7, 2015
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO9 citations83
US7102003B2Sep 5, 2006
Pyrrolotriazine compounds
BRISTOL MYERS SQUIBB CO11 citations82
US7297695B2Nov 20, 2007
Pyrrolotriazine compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO9 citations74
US7141571B2Nov 28, 2006
Pyrrolotriazine compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO8 citations74
US7064203B2Jun 20, 2006
Di-substituted pyrrolotriazine compounds
BRISTOL MYERS SQUIBB CO9 citations74
US9492460B2Nov 15, 2016
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US10053454B2Aug 21, 2018
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US9556178B2Jan 31, 2017
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US9273075B2Mar 1, 2016
Prodrugs of 1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO4 citations70
US7102001B2Sep 5, 2006
Process for preparing pyrrolotriazine
BRISTOL MYERS SQUIBB CO9 citations70
US7846931B2Dec 7, 2010
Pyrrolotriazine compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations63
US7442700B2Oct 28, 2008
Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
BRISTOL MYERS SQUIBB CO5 citations63
US7417040B2Aug 26, 2008
Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
BRISTOL MYERS SQUIBB CO3 citations63
US7378426B2May 27, 2008
Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
BRISTOL MYERS SQUIBB CO2 citations63
US9133139B2Sep 15, 2015
Fluoroalkyl-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO2 citations62
US8940736B2Jan 27, 2015
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US7105537B2Sep 12, 2006
2-substituted cyclic amines as calcium sensing receptor modulators
BRISTOL MYERS SQUIBB CO4 citations61
US12485123B2Dec 2, 2025
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists
BRISTOL MYERS SQUIBB CO0 citations52
US10112941B2Oct 30, 2018
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations52
US9427442B2Aug 30, 2016
Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO0 citations52
US9133126B2Sep 15, 2015
Fluoroalkyl dibenzoazepinone compounds
BRISTOL MYERS SQUIBB CO0 citations52
US7358256B2Apr 15, 2008
ATP competitive kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US10196387B2Feb 5, 2019
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9751879B2Sep 5, 2017
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO1 citations51
US9242940B2Jan 26, 2016
N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO0 citations51
US9187434B2Nov 17, 2015
Substituted 1,5-benzodiazepinones compounds
BRISTOL MYERS SQUIBB CO0 citations51
US9371328B2Jun 21, 2016
Imidazopyridazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
INNATE TUMOR IMMUNITY INC
10 patentsUS11344543B2May 31, 2022
NLRP3 modulators
INNATE TUMOR IMMUNITY INC2 citations72
US12391675B2Aug 19, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US12171756B2Dec 24, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US12492200B2Dec 9, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations59
US12201627B2Jan 21, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations52
US12024513B2Jul 2, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations52
US12338228B2Jun 24, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations51
US12150937B2Nov 26, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations51
US12037344B2Jul 16, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations51
US12187706B2Jan 7, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations50
FINK BRIAN E
2 patentsGAVAI ASHVINIKUMAR V
1 patentMARKWALDER JAY A
1 patentShowing the top 50 of 59 patents by PatentIndex Score.